Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 12/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13909820 | 0.90 | HDAC1 (0.76) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL4887341 | 0.85 | HDAC1 (0.69) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL4562865 | 0.85 | HDAC1 (0.69) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL4065807 | 0.84 | HDAC1 (0.68) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL21055028 | 0.84 | HDAC1 (0.68) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL5575215 | 0.81 | HDAC1 (0.65) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL4070374 | 0.81 | HDAC1 (0.64) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL14037709 | 0.81 | HDAC1 (0.64) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL4066161 | 0.80 | HDAC1 (0.63) | HDAC1HDAC6CXCR4CYP3A4CYP2D6 | |
| SCHEMBL30379489 | 0.79 | HDAC1 (0.61) | HDAC1HDAC6CXCR4CYP2D6P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707931-A | Intermediate and synthesis method of 1- (1-oxo-1, 2-dihydro-phthalazin-6-yl) cycloalkyl-1-carboxamide derivatives as MTA synergistic inhibitors of PRMT5 | 百济神州(北京)生物科技有限公司 | 2025-03-28 | — | — | CN | disclosed |